Search tips
Search criteria 


Logo of bmjThis ArticleThe BMJ
BMJ. 2007 May 19; 334(7602): 1063.
PMCID: PMC1871748

Christopher Charles Draper

After qualifying Christopher Draper did his national service in Japan with the Anzac Medical Service and returned to do several courses at the London School of Hygiene and Tropical Medicine; he was invited to stay on as a junior lecturer, with George McDonald. In 1953 he joined the Colonial Research Service and for six years ran the Pare-Taveta scheme in Tanzania to control malaria and test whether indoor spraying could succeed against hyperendemic malaria. He demonstrated that the worst effects of malaria could be dramatically reduced—notably, a halving of all cause infant mortality.

Christopher went on to serve three years in Nigeria working with viruses. Returning to England, he worked for five years at the Wellcome Foundation on rubella vaccine and early studies of interferon. In 1969 he returned to the London School of Hygiene and Tropical Medicine as a senior lecturer and worked there until his retirement, researching rabies, schistomomiasis, Burkitt's syndrome, and leprosy.

Finally, Christopher concentrated on the emergence of resistant strains of malaria in Tanzania. He was a member of the WHO Advisory Committee on Malaria and on the Tropical Medicine Research Board, travelling to various countries to carry out inspections. His greatest achievement was his early research in seroepidemiology and the use of ELISA tests. In retirement he went to Nepal for the ODA (Overseas Development Agency, now Department for International Development, DIFD) and China for WHO.

He leaves a wife, Katharine, and three children.

Articles from The BMJ are provided here courtesy of BMJ Publishing Group